Literature DB >> 23632762

Characterization of chronic subdural hematoma fluid proteome.

Anna-Leena Heula1, Steffen Ohlmeier, Juha Sajanti, Kari Majamaa.   

Abstract

BACKGROUND: Chronic subdural hematoma (CSDH) is commonly caused by head injury, but the progression of CSDH is recognized as an inflammatory process. The protein composition of the CSDH fluid has not been fully elucidated, nor has the contribution of its components to the enlargement of the hematoma cavity and to its chronic manifestation.
OBJECTIVE: To characterize the protein content of CSDH fluid and study the differences between CSDH fluid and serum to identify proteins putatively involved in the pathogenesis of CSDH.
METHODS: CSDH fluid and serum of 5 patients were investigated with 2-dimensional gel electrophoresis followed by glycosylation-specific fluorescence staining and mass spectrometry.
RESULTS: Two-dimensional gel electrophoresis revealed approximately 1100 protein spots in the CSDH fluid. We identified 213 spots representing 57 different proteins, most of which were glycosylated. The comparison with serum revealed 11 proteins with elevated levels in the CSDH fluid including carbonic anhydrase I, catalase, ferritin light chain, fibrinogen (α, β, γ), hemoglobin (α, β), malate dehydrogenase, peroxiredoxin 2, and transforming growth factor-β-induced protein ig-h3. The levels of haptoglobin and a fragment of complement C4 were decreased. Changes in spot positions were detected for apolipoprotein A1 and a fragment of complement C3.
CONCLUSION: The hematoma fluid originates mainly from blood and the results suggest the involvement of coagulation and fibrinolysis cascades. However, proteins with a potential role in CSDH pathogenesis were detected including carbonic anhydrase I, transforming growth factor-β-induced protein ig-h3, and the altered components of the complement system. Inflammation and fibrosis indicate targets for further studies in the pathogenesis of CSDH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23632762     DOI: 10.1227/01.neu.0000430323.24623.de

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

Review 1.  Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.

Authors:  Ellie Edlmann; Susan Giorgi-Coll; Peter C Whitfield; Keri L H Carpenter; Peter J Hutchinson
Journal:  J Neuroinflammation       Date:  2017-05-30       Impact factor: 8.322

2.  Steroids in chronic subdural hematomas (SUCRE trial): study protocol for a randomized controlled trial.

Authors:  Pierre-Louis Henaux; Pierre-Jean Le Reste; Bruno Laviolle; Xavier Morandi
Journal:  Trials       Date:  2017-06-05       Impact factor: 2.279

Review 3.  Burr hole drainage and burr hole drainage with irrigation to treat chronic subdural hematoma: A systematic review and meta-analysis.

Authors:  Ye Yuan; Qiang-Ping Wang; Yu-Lin Cao; Hongri Zhang; Mohammad Shah Nayaz Burkutally; Kamile Budryte; Nanxiang Xiong
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

4.  Hematoma-derived exosomes of chronic subdural hematoma promote abnormal angiogenesis and inhibit hematoma absorption through miR-144-5p.

Authors:  Chuang Gao; Zhitao Gong; Dong Wang; Jinhao Huang; Yu Qian; Meng Nie; Weiwei Jiang; Xuanhui Liu; Hongliang Luo; Jiangyuan Yuan; Tangtang Xiang; Shuo An; Wei Quan; Huijie Wei; Jianning Zhang; Rongcai Jiang
Journal:  Aging (Albany NY)       Date:  2019-12-16       Impact factor: 5.682

5.  Elevated blood urea nitrogen is associated with recurrence of post-operative chronic subdural hematoma.

Authors:  Ning Wang; Jiangnan Hu; Anthony Oppong-Gyebi; Xuanhao Zhu; Yihao Li; Jianjing Yang; Linhui Ruan; Qichuan Zhuge; Sheng Ye
Journal:  BMC Neurol       Date:  2020-11-10       Impact factor: 2.474

Review 6.  How to remove those bloody collections: Nonsurgical treatment options for chronic subdural hematoma.

Authors:  Ho Jun Yun; Yuchuan Ding
Journal:  Brain Circ       Date:  2020-12-29

7.  Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.

Authors:  Dong-Ling Liu; Zhi Hong; Jing-Ying Li; Yu-Xin Yang; Chu Chen; Jun-Rong Du
Journal:  J Neuroinflammation       Date:  2021-06-24       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.